
Christopher Upton
Examiner (ID: 3762, Phone: (571)272-1169 , Office: P/1778 )
| Most Active Art Unit | 1778 |
| Art Unit(s) | 1797, 1306, 1308, 1776, 1778, 1724 |
| Total Applications | 3146 |
| Issued Applications | 2580 |
| Pending Applications | 123 |
| Abandoned Applications | 451 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7263189
[patent_doc_number] => 20040261139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Androgen receptor knock-out transgenic animals'
[patent_app_type] => new
[patent_app_number] => 10/484950
[patent_app_country] => US
[patent_app_date] => 2004-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 33561
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20040261139.pdf
[firstpage_image] =>[orig_patent_app_number] => 10484950
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/484950 | Androgen receptor knock-out transgenic animals | Aug 15, 2004 | Abandoned |
Array
(
[id] => 7347864
[patent_doc_number] => 20040248140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Nucleotidic sequences having activity of controlling translation efficiency and utilization thereof'
[patent_app_type] => new
[patent_app_number] => 10/500346
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10887
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10500346
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/500346 | Nucleotidic sequences having activity of controlling translation efficiency and utilization thereof | Jul 28, 2004 | Abandoned |
Array
(
[id] => 7060560
[patent_doc_number] => 20050002920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Antigen presenting cells, method for their preparation and their use for cancer vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/898187
[patent_app_country] => US
[patent_app_date] => 2004-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9963
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002920.pdf
[firstpage_image] =>[orig_patent_app_number] => 10898187
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/898187 | Antigen presenting cells, method for their preparation and their use for cancer vaccines | Jul 25, 2004 | Abandoned |
Array
(
[id] => 7328328
[patent_doc_number] => 20040253631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Recombinational cloning using nucleic acids having recombination sites'
[patent_app_type] => new
[patent_app_number] => 10/893235
[patent_app_country] => US
[patent_app_date] => 2004-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 29689
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253631.pdf
[firstpage_image] =>[orig_patent_app_number] => 10893235
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/893235 | Recombinational cloning using nucleic acids having recombination sites | Jul 18, 2004 | Issued |
Array
(
[id] => 7322078
[patent_doc_number] => 20040226052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Methods of producing a target molecule in a transgenic animal and purification of the target molecule'
[patent_app_type] => new
[patent_app_number] => 10/862951
[patent_app_country] => US
[patent_app_date] => 2004-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13761
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20040226052.pdf
[firstpage_image] =>[orig_patent_app_number] => 10862951
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/862951 | Methods of producing a target molecule in a transgenic animal and purification of the target molecule | Jun 7, 2004 | Abandoned |
Array
(
[id] => 7322080
[patent_doc_number] => 20040226053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Methods of producing a target molecule in a transgenic animal and purification of the target molecule'
[patent_app_type] => new
[patent_app_number] => 10/863101
[patent_app_country] => US
[patent_app_date] => 2004-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13763
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20040226053.pdf
[firstpage_image] =>[orig_patent_app_number] => 10863101
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/863101 | Methods of producing a target molecule in a transgenic animal and purification of the target molecule | Jun 7, 2004 | Abandoned |
Array
(
[id] => 585762
[patent_doc_number] => 07442688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-28
[patent_title] => 'Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation'
[patent_app_type] => utility
[patent_app_number] => 10/860373
[patent_app_country] => US
[patent_app_date] => 2004-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 32408
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/442/07442688.pdf
[firstpage_image] =>[orig_patent_app_number] => 10860373
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/860373 | Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation | Jun 2, 2004 | Issued |
Array
(
[id] => 7277676
[patent_doc_number] => 20040237127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation'
[patent_app_type] => new
[patent_app_number] => 10/860724
[patent_app_country] => US
[patent_app_date] => 2004-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 32915
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20040237127.pdf
[firstpage_image] =>[orig_patent_app_number] => 10860724
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/860724 | Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation | Jun 2, 2004 | Issued |
Array
(
[id] => 7256211
[patent_doc_number] => 20040259829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Compositions and methods for sensitizing and inhibiting growth of human tumor cells'
[patent_app_type] => new
[patent_app_number] => 10/858271
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13145
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259829.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858271
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858271 | Compositions and methods for sensitizing and inhibiting growth of human tumor cells | May 31, 2004 | Issued |
Array
(
[id] => 7116617
[patent_doc_number] => 20050069918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'JAB1 as a prognostic marker and a therapeutic target for human cancer'
[patent_app_type] => utility
[patent_app_number] => 10/858869
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 38552
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20050069918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858869
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858869 | JAB1 as a prognostic marker and a therapeutic target for human cancer | May 31, 2004 | Abandoned |
Array
(
[id] => 7195758
[patent_doc_number] => 20050164218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Gene expression markers for response to EGFR inhibitor drugs'
[patent_app_type] => utility
[patent_app_number] => 10/857715
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11953
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164218.pdf
[firstpage_image] =>[orig_patent_app_number] => 10857715
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/857715 | Gene expression markers for response to EGFR inhibitor drugs | May 27, 2004 | Abandoned |
Array
(
[id] => 7432642
[patent_doc_number] => 20040209840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Manipulation of arterial-venous identity'
[patent_app_type] => new
[patent_app_number] => 10/848191
[patent_app_country] => US
[patent_app_date] => 2004-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5023
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209840.pdf
[firstpage_image] =>[orig_patent_app_number] => 10848191
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/848191 | Manipulation of arterial-venous identity | May 17, 2004 | Abandoned |
Array
(
[id] => 7088954
[patent_doc_number] => 20050009067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Expression profile of pancreatic cancer'
[patent_app_type] => utility
[patent_app_number] => 10/848259
[patent_app_country] => US
[patent_app_date] => 2004-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 30895
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009067.pdf
[firstpage_image] =>[orig_patent_app_number] => 10848259
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/848259 | Expression profile of pancreatic cancer | May 17, 2004 | Abandoned |
Array
(
[id] => 5642633
[patent_doc_number] => 20060281088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Markers for lxr activation'
[patent_app_type] => utility
[patent_app_number] => 10/557720
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6876
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281088.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557720
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557720 | Markers for lxr activation | May 13, 2004 | Abandoned |
Array
(
[id] => 7061150
[patent_doc_number] => 20050003511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'New yeast-bacteria shuttle vector'
[patent_app_type] => utility
[patent_app_number] => 10/843542
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6803
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003511.pdf
[firstpage_image] =>[orig_patent_app_number] => 10843542
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/843542 | New yeast-bacteria shuttle vector | May 9, 2004 | Abandoned |
Array
(
[id] => 7183312
[patent_doc_number] => 20040203077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Method and kit for quantitation of polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/473043
[patent_app_country] => US
[patent_app_date] => 2004-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4335
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20040203077.pdf
[firstpage_image] =>[orig_patent_app_number] => 10473043
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/473043 | Method and kit for quantitation of polypeptides | May 3, 2004 | Abandoned |
Array
(
[id] => 7206382
[patent_doc_number] => 20050043260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Wnt as a factor for cardiac myogenesis'
[patent_app_type] => utility
[patent_app_number] => 10/828669
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18389
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043260.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828669
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828669 | Wnt as a factor for cardiac myogenesis | Apr 20, 2004 | Abandoned |
Array
(
[id] => 5216020
[patent_doc_number] => 20070105101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Gene expression associated with osteobla st differentiation'
[patent_app_type] => utility
[patent_app_number] => 10/552319
[patent_app_country] => US
[patent_app_date] => 2004-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23561
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105101.pdf
[firstpage_image] =>[orig_patent_app_number] => 10552319
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/552319 | Gene expression associated with osteobla st differentiation | Apr 4, 2004 | Abandoned |
Array
(
[id] => 5188402
[patent_doc_number] => 20070166710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Methods for inhibiting adipogenesis and for treating type 2 diabetes'
[patent_app_type] => utility
[patent_app_number] => 10/551392
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 21669
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20070166710.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551392
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551392 | Methods for inhibiting adipogenesis and for treating type 2 diabetes | Mar 30, 2004 | Abandoned |
Array
(
[id] => 7672949
[patent_doc_number] => 20040180830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder'
[patent_app_type] => new
[patent_app_number] => 10/806515
[patent_app_country] => US
[patent_app_date] => 2004-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 25735
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180830.pdf
[firstpage_image] =>[orig_patent_app_number] => 10806515
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/806515 | Methods and compositions for preventing and treating male erectile dysfunction | Mar 21, 2004 | Issued |